DAMORA THERAPEUTICS INC (DMRA)
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
$21.86-4.71%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
QuarterlyIQ Insights · DMRA
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -60.3% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 116 industry peers
DMRA — capital allocation — Material Modification to Rights of Security Holders
Dated 2026-07-20
Material Modification to Rights of Security Holders. The Company held a special meeting on February 9, 2026 (the “ Special Meeting ”) to approve all of the proposals in its definitive proxy statement filed on Form DEF 14A with the U.S. Securities and Exchange Commission (the “ SEC ”) on December 31, 2025 (the “ Proxy Statement ”). At the Special Meeting, the Company’s stockholders approved, among other matters, the redomestication of the Company from the State of Delaware to the Cayman Island…
Why it matters: Damora has posted losses and used cash in most recent quarters. A larger loss than Q2 would add pressure to its cash plan.
Worry ifThe Nov. 5 report shows an operating loss above $34.99 million for 2026-Q3.
Less concerning ifThe Nov. 5 report shows an operating loss below $34.99 million, with cash from operations less negative than Q2.
Why it matters: The CFO left in the second quarter, while leadership changes remain active. A named replacement would mark progress on that transition.
Supportive ifDamora names a permanent CFO in its Nov. 5 report or a company filing.
Worry ifDamora says the CFO job is still open, or names another interim CFO.
Why it matters: Damora had about $535 million in cash in February, but cash use was high in the second quarter. The next update can show whether its runway remains on track.
Watch forThe Nov. 5 report shows cash use below $21.87 million for the quarter, with runway still reaching planned Phase 3 work.
Also watch forThe Nov. 5 report shows cash use above $21.87 million for the quarter, or a shorter runway than planned.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$213 on $10,000 · ±2.1% | How much price usually moves either way. |
| Bad day | $960 loss on $10,000 · 9.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,687 loss on $10,000 · 46.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.